RECURRENT CUTANEOUS MELANOMA
Clinical trials for RECURRENT CUTANEOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CUTANEOUS MELANOMA trials appear
Sign up with your email to follow new studies for RECURRENT CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Melanoma drug combo shows promise before surgery in early trial
Disease control TerminatedThis study tested two drugs, encorafenib and binimetinib, given before surgery to people with stage IIIB-D melanoma that had spread to lymph nodes. The goal was to see if the drugs could shrink or eliminate tumors before they were removed. Only 3 people enrolled before the study …
Matched conditions: RECURRENT CUTANEOUS MELANOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
Experimental immune cell combo for Kids' cancers halted early
Disease control TerminatedThis early-phase trial aimed to find the safest dose of donor natural killer (NK) cells combined with chemotherapy for children and young adults with solid tumors that returned or didn't respond to treatment. The NK cells were grown from donated cord blood and given alongside sta…
Matched conditions: RECURRENT CUTANEOUS MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:37 UTC